Articles tagged with Hiv Infections
Researchers at Harvard Medical School have successfully used RNA interference (RNAi) to prevent the spread of HIV in mice. The study found that knocking down three specific genes in T cells protected them from the virus, preventing it from jumping between cells.
A new study has identified younger, recently diagnosed men and those who binge drink and use substances like methamphetamine as high-risk groups for HIV transmission. These findings suggest the need for more targeted prevention programs to address the rising rates of HIV diagnoses among these men.
Robert Siliciano, an HIV expert, says that current antiretroviral drug combinations can suppress the ability of HIV to replicate, with some combos reducing copies to less than one in a billion. However, progress is still needed to identify and eliminate viral reservoirs that persist in the body.
Researchers at the University of Montreal and Argos Therapeutics have developed a novel method to create personalized immunotherapy treatments for HIV. The treatment uses dendritic cell-based therapies that stimulate the expansion of HIV-specific T cells, which attack and kill infected cells.
Researchers found that fibrosis occurs rapidly in the gut, limiting drug effectiveness and making it harder to restore immunity. Early treatment can preserve some elements of the immune system by protecting T-cells.
The Lancet series highlights the importance of combination prevention approaches, combining behavioural, medical, and structural strategies. The authors warn that global prevention efforts are woefully insufficient, with fewer than 10% of individuals at risk receiving key services.
To reduce HIV transmission, radical behavioral change is necessary, involving a range of strategies including increasing HIV knowledge, decreasing risky behaviors, and providing access to treatment. The authors emphasize the need for sustainable commitment and proper resources to implement these prevention strategies.
A study by Emory University researchers found that black girls who use marijuana have significantly higher rates of incident STDs than non-users. Marijuana users also had more sex partners and riskier sex acts, including those with recently released jail partners.
Researchers argue that structural approaches can significantly reduce HIV risk and vulnerability, particularly in addressing gender inequality and economic dependence. Examples of successful initiatives include needle exchange programmes and empowering sex workers to take control of their own health.
Researchers recommend using prophylactic antiretroviral (ARV) drugs to reduce infectiousness among HIV-positive individuals. Male circumcision is also shown to significantly reduce the risk of HIV transmission. Providing contraception for HIV-positive women can further prevent mother-to-baby transmission and unintended pregnancies.
A study published in The Lancet Infectious Diseases found that the common HIV infectivity rate of 1 transmission per 1000 contacts is inaccurate and significantly underestimates actual transmission rates. The study estimated varying degrees of risk, including a 300-fold difference between different types of contact.
A study found that a rectal tenofovir gel can prevent the transmission of an AIDS-like virus in macaques. The gel was applied before exposure and protected most animals from infection. However, more research is needed to confirm its effectiveness in humans.
A new study suggests that male circumcision can overcome cultural and safety concerns, increasing penile sensitivity and reducing risky behaviors. Implementing circumcision programs in eastern and southern Africa could prevent an estimated two million HIV infections over the next decade.
The International AIDS Society–USA Panel updated treatment guidelines to reflect recent data on antiretroviral therapy. The new guidelines recommend starting therapy before CD4 cell count declines to less than 350/μL, with individualized regimens tailored to patient needs.
A recent study published in the peer-reviewed journal AIDS found a significant association between bacterial vaginosis and an increased risk of HIV infection. The analysis of over 30,700 women from around the world showed that women with BV were more likely to acquire HIV than those without it.
Researchers will explore how HIV infection causes immune activation and depletion, with potential for clinical applications in AIDS treatment. The grant supports four projects ranging from basic lab research to experimental models and translational research.
A bi-national study found that male injection drug users deported from the US to Tijuana have a four-fold higher risk of HIV infection. The study suggests a need for cross-border prevention and treatment programs.
A new study published in The Lancet warns that HIV transmission could quadruple in certain populations if people with HIV follow potentially misleading advice. Mathematical modeling predicts that HIV transmission would be four times higher in serodiscordant couples who abandon condom use.
Researchers at Wake Forest University Baptist Medical Center have disproven the long-held belief that hepatitis C virus slows immune system recovery after HIV treatment. The study found no difference in CD4 cell restoration between co-infected and mono-infected patients, suggesting other factors are at play.
A recent study estimates that if couples stop using condoms, HIV incidence could easily quadruple over 10 years. The risk of transmission from effectively treated patients is low but non-zero, and transmission risks are higher in male homosexual partnerships.
TB is a threat throughout the course of HIV disease, and addressing it is crucial for saving patient lives and curbing the global TB burden. The authors propose several strategic approaches, including intensified case finding, treating individuals with active TB, and implementing infection control measures.
A recent study published in PLoS Neglected Tropical Diseases found that parasitic worm infections can increase the risk of acquiring HIV/AIDS. The study showed that rhesus macaques with acute schistosomiasis were more susceptible to an HIV-like virus, with higher peak viral loads and memory cell concentrations.
Researchers at Massachusetts General Hospital found that HIV can escape the immune system by exchanging genetic information with other strains, leading to more potent strains. This mechanism, known as superinfection, can cause rapid increases in viral levels and poses a challenge for vaccine design.
Social taboos and stigma surrounding homosexuality make it difficult to control the HIV epidemic among Pakistani men who have sex with men. Outreach programs need to target subpopulations and address specific challenges such as promoting safe sex and reducing stigma around condoms.
Researchers at Duke University Medical Center found that HIV-1 cripples the immune system earlier than previously believed, with significant cell death occurring within five to seven days after infection. The study suggests a new approach to vaccine design, requiring multiple arms of the immune system to be activated and targeted.
The National Institute of Allergy and Infectious Diseases has decided not to conduct the PAVE 100 HIV vaccine trial, but will consider a smaller study to determine if the VRC vaccine regimen significantly lowers viral load. The decision comes after analyzing the STEP HIV vaccine study results, which found increased numbers of HIV infec...
A gene variant found only in people of African ancestry increases the risk of becoming infected with HIV-1, but those who carry it may live up to two years longer after infection. The variant affects a protein on red blood cells that is also involved in protecting against malaria.
A genetic variation that protects against malaria increases susceptibility to HIV by up to 40%, yet also prolongs survival by approximately two years. This finding highlights the complex relationship between genetics and HIV/AIDS, with implications for targeted prevention strategies.
A study by Dr. Nicole Bernard of McGill University Health Centre found that specific genes KIR3DL1 and HLA-B*57 provide innate resistance to HIV infection. People carrying these gene versions may be able to destroy infected cells more efficiently, lowering their risk of developing AIDS.
Researchers at UT Medical School have pinpointed the Achilles heel of HIV in the envelope protein gp120, a region essential for viral attachment to host cells. Engineered antibodies with enzymatic activity, or abzymes, can attack this weak spot, offering new hope for therapeutic intervention and prevention.
Scientists discovered that HIV depletes functional B cells, which produce antibodies. The fatigued B cells overexpress the protein FCRL4, dampening their response to infection.
New UCLA study suggests that vaginal microbicides, currently being developed for women, might be more effective in preventing HIV infections in men. The study found that if the efficacy of these microbicides is less than 50% and adherence is less than 60%, they could prevent up to 21% of HIV infections in men.
A study published in JAMA found that HIV-infected individuals in industrialized countries now have mortality rates similar to the general population in the first 5 years following infection. However, longer-term excess mortality remains evident, with higher risks for older age groups and injection drug users.
A meta-analysis of 38 randomized controlled trials found that interventions incorporating these characteristics significantly reduced HIV risk behaviors and sexually transmitted infections. The study emphasizes the importance of understanding diversity within African American communities in developing effective interventions.
A study found that 55-93% of new HIV infections among adults in urban Zambia and Rwanda occur within marital or cohabiting couples, with potential for increased transmission if non-cohabiting partners use condoms. Interventions targeting couples could avert 36-60% of heterosexually transmitted infections.
The University of Pennsylvania School of Medicine team proposes a new policy requiring transplant programs to disclose all foreseeable risks of the surgery to potential recipients at the waiting list. This change aims to promote greater equity in organ allocation and restrict 'cherry-picking' of organs from suitable but suboptimal donors.
A new study published in PLOS Medicine found that a brief video intervention in clinic waiting rooms can significantly reduce the incidence of new sexually transmitted infections among patients. The Safe in the City video, which is available online, was shown to lower STD rates by nearly 10% compared to those who did not watch the video.
A trial found that aciclovir did not reduce the risk of HIV-1 infection in HSV-2 positive women and MSM. However, it did reduce incidence of genital ulcers by 47% and HSV-2 ulcers by 63%. The authors suggest novel strategies are needed to interrupt interactions between HSV-2 and HIV-1.
Researchers found a faster disease course and increased HIV entry in patients with the apoE4 allele. The study suggests apoE4 may have clinical applicability in treating both Alzheimer's and HIV diseases.
Two studies suggest breastfeeding can reduce infant mortality and HIV infection rates, particularly among infected infants. In resource-poor settings, abrupt cessation of breastfeeding after four months may be harmful, while extended anti-HIV treatment can greatly reduce the risk of infection.
A team of researchers at The Scripps Research Institute identified molecular changes in the cerebrospinal fluid of monkeys infected with SIV, which can cause CNS damage. This approach may provide new information about other neurodegenerative and neuropsychiatric disorders.
A new study published in PLOS Medicine has found that circumcision is safe for both HIV-infected and HIV-uninfected men, with a low risk of moderate or severe surgical complications. The study also highlights the importance of refraining from intercourse after circumcision to prevent transmission of HIV to women partners.
Researchers identify increased fatty acids and phospholipids in CSF of SIV-infected monkeys, linked to CNS damage. The study provides insights into mechanisms of CNS damage in HIV patients using global metabolomics approach.
The new GSID HIV Data Browser provides a wealth of data collected during clinical trials of an AIDS vaccine, offering researchers a unique opportunity to study how the virus evolves and causes new infections. The browser links to preserved specimens and clinical information, allowing investigators to study the evolution of the virus an...
Researchers discovered that HIV protease inhibitors can prevent photoreceptor apoptosis in mouse models of retinal detachment, reducing the cause of vision loss. CD133 expression was found not to be restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells can initiate tumors.
Advances in sequencing and surveillance have enabled researchers to identify circulating strains of HIV-1, with subtype B prevalent in the Americas and clades A, C, and D in Sub-Saharan Africa. The study highlights the importance of viral diversity on disease progression and transmission.
A new study reveals that among billions of HIV variants, only a few lead to sexual transmission. The researchers used genetic analysis and mathematical modeling to identify precisely those viruses responsible for HIV transmission.
Dr. Fauci outlines the peaks and valleys of HIV/AIDS research, from initial diagnosis challenges to breakthroughs with protease inhibitors and combination therapies. He emphasizes the need for continued research into a cure and prevention through vaccine development.
A study published in New England Journal of Medicine identified efavirenz with NRTI as the most effective initial therapy for HIV-1 infection, achieving high viral suppression rates. The finding offers a valuable alternative to traditional triple-drug regimens and could lead to simpler treatment regimens.
Researchers argue that male circumcision and reducing multiple sexual partners are more effective HIV prevention strategies than condom promotion, HIV testing, and other approaches. Studies have shown significant reductions in HIV risk with these interventions, particularly in west Africa and Uganda.
Researchers found that antidepressant medications increased natural killer cell activity in HIV-infected women with and without depression. The study suggests a potential link between antidepressant treatment and improved innate immunity, which could delay HIV disease progression.
The study found that 95% of participants completed the program, linking them to medical care for a year after release. This continuity of care improved health outcomes, reduced costs, and may have reduced HIV transmission. Researchers credited the use of professional social workers with the program's success.
A program in rural India found that round-the-clock rapid HIV testing in labor wards reduced the risk of mother-to-child transmission. The study demonstrated the feasibility of such a program, which led to reduced morbidity and improved health outcomes for mothers and their children.
A study published in PLoS Medicine found that high HIV loads cause CD8+ T cell exhaustion, while reducing antigen levels allows these cells to recover their functions. This suggests that immune exhaustion is a consequence of persistent HIV replication rather than its cause.
Researchers at PARC-MGH found that chronic viral replication leads to exhaustion of HIV-specific T cells. The study suggests that understanding the nature of CTL responses is crucial for designing effective vaccines against HIV. Persistent exposure to specific viral protein segments appears to be the key factor in CTL exhaustion.
A new study has identified a human protein that can be targeted to block HIV infection, offering a potential breakthrough in the fight against AIDS. By inactivating this protein, called interleukin-2-inducible T cell kinase (ITK), researchers have found that HIV's ability to infect and replicate within immune cells is slowed or blocked.
A study found that micronutrient supplementation reduced TB recurrence rates in patients undergoing chemotherapy. The study showed a 45% overall reduction and a 63% decrease for HIV-infected patients.
Research published in PLOS Medicine found that interleukin-6 levels are associated with coronary heart disease, suggesting it could be a target for drug development. Two new methods were also developed to estimate HIV incidence based on changes in cross-sectional prevalence, showing sufficient accuracy for monitoring the epidemic.
Scientists believe that HIV's lack of protection against immune system activation makes it more virulent in humans. Researchers are studying whether artificially disabling this protective function could make SIVs more pathogenic in their natural hosts.
Researchers have discovered how HIV evades the immune system by altering a key defence mechanism. The Nef protein interferes with the recognition of infected cells, making it difficult for the body to target and eliminate the virus.